Skip to Content

T. Rowe Price International Value Eq R RRIGX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 17.71  /  +1.14 %
  • Total Assets 12.1 Bil
  • Adj. Expense Ratio
    1.310%
  • Expense Ratio 1.310%
  • Distribution Fee Level Average
  • Share Class Type Retirement, Medium
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 2.25%
  • Turnover 18%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis RRIGX

Will RRIGX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still more attractive than most of its competitors.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

T. Rowe Price International Value continues to enjoy a variety of advantages over its rivals, and it remains an appealing source of foreign large-value exposure for long-term investors.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RRIGX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 19.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AstraZeneca PLC ADR

2.88 342.0 Mil
Healthcare

Trp Government Reserve

2.33 277.3 Mil
Cash and Equivalents

TotalEnergies SE

2.23 265.5 Mil
Energy

Rolls-Royce Holdings PLC

2.09 248.0 Mil
Industrials

ING Groep NV

2.05 243.4 Mil
Financial Services

Sanofi SA

1.76 208.8 Mil
Healthcare

Toyota Motor Corp

1.72 203.9 Mil
Consumer Cyclical

Hitachi Ltd

1.71 203.1 Mil
Industrials

AXA SA

1.59 189.5 Mil
Financial Services

Roche Holding AG

1.58 187.4 Mil
Healthcare